BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9490670)

  • 21. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.
    Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
    Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
    Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
    Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type J CBFbeta/MYH11 transcript in the M4Eo subtype of acute myeloid leukemia.
    Trnková Z; Peková S; Bedrlíková R; Záková D; Zemanová Z; Polák J; Michalová K; Cermák J; Schwarz J
    Hematology; 2003 Apr; 8(2):115-7. PubMed ID: 12745661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study.
    Mitterbauer M; Laczika K; Novak M; Mitterbauer G; Hilgarth B; Pirc-Danoewinata H; Schwarzinger I; Haas OA; Fonatsch C; Lechner K; Jaeger U
    Am J Clin Pathol; 2000 Mar; 113(3):406-10. PubMed ID: 10705822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
    Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia.
    Claxton DF; Liu P; Hsu HB; Marlton P; Hester J; Collins F; Deisseroth AB; Rowley JD; Siciliano MJ
    Blood; 1994 Apr; 83(7):1750-6. PubMed ID: 8142642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
    Buonamici S; Ottaviani E; Testoni N; Montefusco V; Visani G; Bonifazi F; Amabile M; Terragna C; Ruggeri D; Piccaluga PP; Isidori A; Malagola M; Baccarani M; Tura S; Martinelli G
    Blood; 2002 Jan; 99(2):443-9. PubMed ID: 11781223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients.
    Mancini M; Cedrone M; Diverio D; Emanuel B; Stul M; Vranckx H; Brama M; De Cuia MR; Nanni M; Fazi F; Mecucci C; Alimena G; Hagemeijer A
    Leukemia; 2000 Mar; 14(3):364-8. PubMed ID: 10720127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
    Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
    Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
    Rowe D; Cotterill SJ; Ross FM; Bunyan DJ; Vickers SJ; Bryon J; McMullan DJ; Griffiths MJ; Reilly JT; Vandenberghe EA; Wilson G; Watmore AE; Bown NP
    Br J Haematol; 2000 Dec; 111(4):1051-6. PubMed ID: 11167739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
    Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
    Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.
    Hernández JM; González MB; Granada I; Gutiérrez N; Chillón C; Ramos F; Ribera JM; González M; Feliu E; San Miguel J
    Haematologica; 2000 May; 85(5):481-5. PubMed ID: 10800163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MN1 overexpression is an important step in the development of inv(16) AML.
    Carella C; Bonten J; Sirma S; Kranenburg TA; Terranova S; Klein-Geltink R; Shurtleff S; Downing JR; Zwarthoff EC; Liu PP; Grosveld GC
    Leukemia; 2007 Aug; 21(8):1679-90. PubMed ID: 17525718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz MA
    Haematologica; 2000 Jul; 85(7):699-703. PubMed ID: 10897121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation.
    Ritter M; Thiede C; Schäkel U; Schmidt M; Alpen B; Pascheberg U; Mohr B; Ehninger G; Neubauer A
    Br J Haematol; 1997 Sep; 98(4):969-72. PubMed ID: 9326197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping.
    Sun X; Zhang W; Ramdas L; Stivers DN; Jones DM; Kantarjian HM; Estey EH; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
    Mod Pathol; 2007 Aug; 20(8):811-20. PubMed ID: 17571080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid sarcoma of the small bowel associated with a CBFbeta/MYH11 fusion and inv(16)(p13q22): a case report.
    McKenna M; Arnold C; Catherwood MA; Humphreys MW; Cuthbert RJ; Bueso-Ramos C; McManus DT
    J Clin Pathol; 2009 Aug; 62(8):757-9. PubMed ID: 19638550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of minimally differentiated acute myeloid leukemia with chromosome 16 inversion.
    Sotomatsu M; Ogawa C; Shimoda M; Matsui A; Nakazawa S; Eguchi M; Morikawa A
    Leuk Lymphoma; 1997 Jan; 24(3-4):319-25. PubMed ID: 9156661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
    Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
    Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.